These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

300 related items for PubMed ID: 18413206

  • 1. Rosiglitazone protects diabetic rats against kidney disease through the suppression of renal moncyte chemoattractant protein-1 expression.
    Zheng M, Ye S, Zhai Z, Chen Y, Li X, Yang G, Fan A, Wang Y.
    J Diabetes Complications; 2009; 23(2):124-9. PubMed ID: 18413206
    [Abstract] [Full Text] [Related]

  • 2. Rosiglitazone protects diabetic rats against kidney injury through the suppression of renal matrix metalloproteinase-9 expression.
    Yao XM, Ye SD, Chen Y, Zai ZM, Li XC, Wang YX, Chen K.
    Diabetes Obes Metab; 2009 May; 11(5):519-22. PubMed ID: 19236438
    [Abstract] [Full Text] [Related]

  • 3. Experimental study of leflunomide on renal protective effect and on inflammatory response of streptozotocin induced diabetic rats.
    Yu WM, Wang H, Ren XJ, Liu JP, Wang JY.
    Nephrology (Carlton); 2012 May; 17(4):380-9. PubMed ID: 22243699
    [Abstract] [Full Text] [Related]

  • 4. Protective effect of a poly-phytocompound on early stage nephropathy secondary to experimentally-induced diabetes.
    Marotta F, Harada M, Dallah ED, Yadav H, Solimene U, Di Lembo S, Minelli E, Jain S, Chui DH.
    J Biol Regul Homeost Agents; 2010 May; 24(1):41-9. PubMed ID: 20385070
    [Abstract] [Full Text] [Related]

  • 5. Pioglitazone attenuates diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats.
    Ko GJ, Kang YS, Han SY, Lee MH, Song HK, Han KH, Kim HK, Han JY, Cha DR.
    Nephrol Dial Transplant; 2008 Sep; 23(9):2750-60. PubMed ID: 18388116
    [Abstract] [Full Text] [Related]

  • 6. Effect of rosiglitazone on the expression of cardiac adiponectin receptors and NADPH oxidase in type 2 diabetic rats.
    Guo Z, Qin Z, Zhang R, Li J, Yin Y.
    Eur J Pharmacol; 2012 Jun 15; 685(1-3):116-25. PubMed ID: 22542658
    [Abstract] [Full Text] [Related]

  • 7. Effects of sildenafil on oxidative and inflammatory injuries of the kidney in streptozotocin-induced diabetic rats.
    Jeong KH, Lee TW, Ihm CG, Lee SH, Moon JY, Lim SJ.
    Am J Nephrol; 2009 Jun 15; 29(3):274-82. PubMed ID: 18812693
    [Abstract] [Full Text] [Related]

  • 8. Simvastatin protects diabetic rats against kidney injury through the suppression of renal matrix metalloproteinase-9 expression.
    Yao XM, Ye SD, Zai Z, Chen Y, Li XC, Yang GW, Wang YX, Chen K.
    J Endocrinol Invest; 2010 May 15; 33(5):292-6. PubMed ID: 19820293
    [Abstract] [Full Text] [Related]

  • 9. Protective effect of polyphenol-containing azuki bean (Vigna angularis) seed coats on the renal cortex in streptozotocin-induced diabetic rats.
    Sato S, Yamate J, Hori Y, Hatai A, Nozawa M, Sagai M.
    J Nutr Biochem; 2005 Sep 15; 16(9):547-53. PubMed ID: 16115543
    [Abstract] [Full Text] [Related]

  • 10. Colchicine attenuates inflammatory cell infiltration and extracellular matrix accumulation in diabetic nephropathy.
    Li JJ, Lee SH, Kim DK, Jin R, Jung DS, Kwak SJ, Kim SH, Han SH, Lee JE, Moon SJ, Ryu DR, Yoo TH, Han DS, Kang SW.
    Am J Physiol Renal Physiol; 2009 Jul 15; 297(1):F200-9. PubMed ID: 19369290
    [Abstract] [Full Text] [Related]

  • 11. Effects of benazepril on renal function and kidney expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in diabetic rats.
    Sun SZ, Wang Y, Li Q, Tian YJ, Liu MH, Yu YH.
    Chin Med J (Engl); 2006 May 20; 119(10):814-21. PubMed ID: 16732983
    [Abstract] [Full Text] [Related]

  • 12. Renoprotective effect of rosiglitazone through the suppression of renal intercellular adhesion molecule-1 expression in streptozotocin-induced diabetic rats.
    Qian Y, Li S, Ye S, Chen Y, Zhai Z, Chen K, Yang G.
    J Endocrinol Invest; 2008 Dec 20; 31(12):1069-74. PubMed ID: 19246972
    [Abstract] [Full Text] [Related]

  • 13. Spironolactone prevents diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats.
    Han SY, Kim CH, Kim HS, Jee YH, Song HK, Lee MH, Han KH, Kim HK, Kang YS, Han JY, Kim YS, Cha DR.
    J Am Soc Nephrol; 2006 May 20; 17(5):1362-72. PubMed ID: 16571782
    [Abstract] [Full Text] [Related]

  • 14. Tumor necrosis factor-alpha gene expression in diabetic nephropathy: relationship with urinary albumin excretion and effect of angiotensin-converting enzyme inhibition.
    Navarro JF, Milena FJ, Mora C, León C, Claverie F, Flores C, García J.
    Kidney Int Suppl; 2005 Dec 20; (99):S98-102. PubMed ID: 16336586
    [Abstract] [Full Text] [Related]

  • 15. Mesenchymal stem cells transplantation ameliorates glomerular injury in streptozotocin-induced diabetic nephropathy in rats via inhibiting macrophage infiltration.
    Lv SS, Liu G, Wang JP, Wang WW, Cheng J, Sun AL, Liu HY, Nie HB, Su MR, Guan GJ.
    Int Immunopharmacol; 2013 Oct 20; 17(2):275-82. PubMed ID: 23791972
    [Abstract] [Full Text] [Related]

  • 16. Rosiglitazone ameliorates diabetic nephropathy by inhibiting reactive oxygen species and its downstream-signaling pathways.
    Bao Y, Jia RH, Yuan J, Li J.
    Pharmacology; 2007 Oct 20; 80(1):57-64. PubMed ID: 17534120
    [Abstract] [Full Text] [Related]

  • 17. Renal pro-inflammatory cytokine gene expression in diabetic nephropathy: effect of angiotensin-converting enzyme inhibition and pentoxifylline administration.
    Navarro JF, Milena FJ, Mora C, León C, García J.
    Am J Nephrol; 2006 Oct 20; 26(6):562-70. PubMed ID: 17167242
    [Abstract] [Full Text] [Related]

  • 18. Messenger RNA expression of target genes in the urinary sediment of patients with chronic kidney diseases.
    Szeto CC, Chan RW, Lai KB, Szeto CY, Chow KM, Li PK, Lai FM.
    Nephrol Dial Transplant; 2005 Jan 20; 20(1):105-13. PubMed ID: 15561743
    [Abstract] [Full Text] [Related]

  • 19. Effect of retinoic acid in experimental diabetic nephropathy.
    Han SY, So GA, Jee YH, Han KH, Kang YS, Kim HK, Kang SW, Han DS, Han JY, Cha DR.
    Immunol Cell Biol; 2004 Dec 20; 82(6):568-76. PubMed ID: 15550114
    [Abstract] [Full Text] [Related]

  • 20. Peroxisome proliferator-activated receptor gamma agonist improves arterial stiffness in patients with type 2 diabetes mellitus and coronary artery disease.
    Yu J, Jin N, Wang G, Zhang F, Mao J, Wang X.
    Metabolism; 2007 Oct 20; 56(10):1396-401. PubMed ID: 17884451
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.